Literature DB >> 8711059

Behavioural consequences of maternal exposure to natural cannabinoids in rats.

M Navarro1, P Rubio, F R de Fonseca.   

Abstract

Cannabis sativa preparations (hashish, marijuana) are the most widely used illicit drugs during pregnancy in Western countries. The possible long-term consequences for the child of in utero exposure to cannabis derivatives are still poorly understood. Animal models of perinatal cannabinoid exposure provide a useful tool for examining the developmental effects of cannabinoids. Behavioral consequences of maternal exposure to either cannabis preparations or to its main psychoactive component, delta 9-tetrahydrocannabinol (THC) in rat models are reviewed in this paper. Maternal exposure to cannabinoids resulted in alteration in the pattern of ontogeny of spontaneous locomotor and exploratory behavior in the offspring. Adult animals exposed during gestational and lactational periods exhibited persistent alterations in the behavioral response to novelty, social interactions, sexual orientation and sexual behavior. They also showed a lack of habituation and reactivity to different illumination conditions. Adult offspring of both sexes also displayed a characteristic increase in spontaneous and water-induced grooming behavior. Some of the effects were dependent on the sex of the animals being studied, and the dose of cannabinoid administered to the mother during gestational and lactational periods. Maternal exposure to low doses of THC sensitized the adult offspring of both sexes to the reinforcing effects of morphine, as measured in a conditioned place preference paradigm. The existence of sexual dimorphisms on the developmental effects of cannabinoids, the role of sex steroids, glucocorticoids, and pituitary hormones, the possible participation of cortical projecting monoaminergic systems, and the mediation of the recently described cannabinoid receptors are also analyzed. The information obtained in animal studies is compared to the few data available on the long-term behavioral and cognitive effects on in utero exposure to cannabis in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8711059     DOI: 10.1007/BF02246436

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  87 in total

1.  The effects of prenatal exposure to delta-9-tetrahydrocannabinol on the rest-activity cycle of the preweanling rat.

Authors:  D E Hutchings; Z Gamagaris; N Miller; T A Fico
Journal:  Neurotoxicol Teratol       Date:  1989 Jul-Aug       Impact factor: 3.763

Review 2.  The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells.

Authors:  A C Howlett; T M Champion-Dorow; L L McMahon; T M Westlake
Journal:  Pharmacol Biochem Behav       Date:  1991-11       Impact factor: 3.533

Review 3.  Sex steroids and afferent input: their roles in brain sexual differentiation.

Authors:  C Beyer; H H Feder
Journal:  Annu Rev Physiol       Date:  1987       Impact factor: 19.318

4.  Regulation of visual attention in offspring of female monkeys treated chronically with delta 9-tetrahydrocannabinol.

Authors:  M S Golub; E N Sassenrath; L F Chapman
Journal:  Dev Psychobiol       Date:  1981-12       Impact factor: 3.038

Review 5.  Gonadal steroid induction of structural sex differences in the central nervous system.

Authors:  A P Arnold; R A Gorski
Journal:  Annu Rev Neurosci       Date:  1984       Impact factor: 12.449

6.  Delayed sexual maturation during prepubertal cannabinoid treatment: importance of the timing of treatment.

Authors:  E Field; L Tyrey
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

7.  Postnatal ontogenesis of the dopaminergic innervation in the rat anterior cingulate cortex (area 24). Immunocytochemical and catecholamine fluorescence histochemical analysis.

Authors:  B Berger; C Verney; A Febvret; A Vigny; K B Helle
Journal:  Brain Res       Date:  1985-07       Impact factor: 3.252

8.  Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.

Authors:  S Dalterio; R Steger; D Mayfield; A Bartke
Journal:  Pharmacol Biochem Behav       Date:  1984-01       Impact factor: 3.533

9.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex.

Authors:  J Chen; W Paredes; J H Lowinson; E L Gardner
Journal:  Eur J Pharmacol       Date:  1990-11-06       Impact factor: 4.432

View more
  27 in total

1.  Neuroimaging of prenatal drug exposure.

Authors:  Diana L Dow-Edwards; Helene Benveniste; Marylou Behnke; Emmalee S Bandstra; Lynn T Singer; Yasmin L Hurd; L R Stanford
Journal:  Neurotoxicol Teratol       Date:  2006 May-Jun       Impact factor: 3.763

Review 2.  Cannabis use in pregnancy and early life and its consequences: animal models.

Authors:  Miriam Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

3.  Altered motor development following late gestational alcohol and cannabinoid exposure in rats.

Authors:  Kristen R Breit; Brandonn Zamudio; Jennifer D Thomas
Journal:  Neurotoxicol Teratol       Date:  2019-03-31       Impact factor: 3.763

Review 4.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

5.  Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections.

Authors:  Chia-Shan Wu; Jie Zhu; Jim Wager-Miller; Shan Wang; Dennis O'Leary; Krisztina Monory; Beat Lutz; Ken Mackie; Hui-Chen Lu
Journal:  Eur J Neurosci       Date:  2010-07-28       Impact factor: 3.386

6.  Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release.

Authors:  Giampaolo Mereu; Mauro Fà; Luca Ferraro; Raffaele Cagiano; Tiziana Antonelli; Maria Tattoli; Veronica Ghiglieri; Sergio Tanganelli; Gian Luigi Gessa; Vincenzo Cuomo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

Review 7.  Cannabis use during pregnancy: Pharmacokinetics and effects on child development.

Authors:  Kimberly S Grant; Rebekah Petroff; Nina Isoherranen; Nephi Stella; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2017-08-25       Impact factor: 12.310

8.  Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats.

Authors:  Viviana Trezza; Patrizia Campolongo; Tommaso Cassano; Teresa Macheda; Pasqua Dipasquale; Maria Rosaria Carratù; Silvana Gaetani; Vincenzo Cuomo
Journal:  Psychopharmacology (Berl)       Date:  2008-05-02       Impact factor: 4.530

9.  Perinatal delta-9-tetrahydrocannabinol exposure disrupts social and open field behavior in adult male rats.

Authors:  R J Newsom; S J Kelly
Journal:  Neurotoxicol Teratol       Date:  2007-12-31       Impact factor: 3.763

Review 10.  Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions.

Authors:  Luca Ferraro; M C Tomasini; S Beggiato; S Gaetani; T Cassano; V Cuomo; S Amoroso; S Tanganelli; T Antonelli
Journal:  J Neural Transm (Vienna)       Date:  2009-05-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.